A Single Agent Phase II Study of Romidepsin (Depsipeptide, FK228) in the Treatment of Cutaneous T-cell Lymphoma (CTCL)

Top Searches

Healthy Volunteers

Endometriosis

Uterine Fibroids

Depression

Back Pain

Alzheimer's Disease

Mild Cognitive Impairment (MCI)

Ankylosing Spondylitis

Crohn's Disease

Irritable Bowel Syndrome (IBS, Spastic Colon)

Alzheimer's Disease

Choose the location closest to you

6 studies found

UCLA Jonsson Cancer Center
Los Angeles, California 90095

Stanford Comprehensive Cancer Center
Stanford, California 94305

Boston Medical Center
Boston, Massachusetts 02118

University of Pennsylvania Abrahamson Cancer Center
Philadelphia, Pennsylvania 19104

Vanderbilt-Ingram Cancer Center
Nashville, Tennessee 37232

MD Anderson Cancer Center
Houston, Texas 77030

<1>

© 1998-2018 | All trademarks are property of their legal owners. | All Rights Reserved

ClinicalConnection.com is a resource that provides information on clinical trials conducted worldwide.

ClinicalConnection.com does not conduct or endorse clinical trials. Please consult your physician before participating.

Latest Health News

A Wilderness Expert's Keys to Safety in the Great Outdoors August 18, 2018 09:00 AM
Is a Haywire Body Clock Tied to Mood Disorders? August 17, 2018 04:00 PM
More Opioid Users Getting Treatment Since Medicaid Expansion August 17, 2018 02:00 PM
Genetic Testing for Cancer Lacking for Women on Medicare: Study August 17, 2018 02:00 PM

Useful Links

Contact Us

233 Needham Street
Newton, MA 02464
1-800-887-0639
info@clinicalconnection.com
Click here to contact us

1998-2018 © All Rights Reserved. Privacy Policy | Terms of Service